The International Eosinophil Society (IES) is a global community of scientists and clinicians united in advancing understanding and treatment of eosinophil-related diseases, leading to improved patient outcomes and enhanced quality of life.
News
Late-Breaking Abstract Submission
Late-Breaking Abstract submissions are being accepted until 15 May 2025.
Take advantage of Early Registration Rates for the 2025 IES Congress by 1 May 2025!
Beyond the Bite: EoE and Food Allergy
Check out Beyond the Bite: EoE and Food Allergy—a powerful video raising awareness of eosinophilic gastrointestinal disorders and other rare diseases.
Watch here!
Membership Renewal Now Open for the 2025–2026 Term
*NEW* Regular Members get dual membership with EMBRN at no extra cost!
Free Early Career Memberships for pre-doctoral students, post-docs, clinical fellows & residents.
Single Cell Dissection of Human Mast Cells, Basophils and Eosinophils
Speakers:
Daniel Dwyer, PhD
Joakim Dahlin, PhD
Netali Ben-Baruch Morgenstern, PhD
Eosinophils in Check: The Promise of Benralizumab in EGPA Management
Reviewed by Federico Spataro & Antonio Giovanni Solimando, University of Bari, Italy
Eosinophils Under Fire: Benralizumab for Eosinophilic Asthma and COPD Exacerbations
Reviewed by Carlos Andrés Celis-Preciado, University of Sherbrooke, Canada
Explore the latest published research from the 2023 IES Congress, now available in the Journal of Leukocyte Biology. A comprehensive issue with these and more contributions is coming soon. Stay tuned for updates!
13th Biennial Congress
7-11 July 2025
Montpellier, France
The 13th Biennial Congress of the International Eosinophil Society (IES) in 2025 will unite global experts to advance eosinophil research through cutting-edge sessions and collaborative discussions. Join us as we explore new frontiers in the field and strengthen global connections within the eosinophil research community.
